Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
1.796
-0.010 (-0.58%)
Aug 7, 2025, 4:00 PM - Market closed
Minerva Neurosciences Market Cap
Minerva Neurosciences has a market cap or net worth of $12.56 million as of August 8, 2025. Its market cap has decreased by -45.16% in one year.
Market Cap
12.56M
Enterprise Value
55.27M
1-Year Change
-45.16%
Ranking
Category
Stock Price
$1.80
Market Cap Chart
Since July 1, 2014, Minerva Neurosciences's market cap has decreased from $110.60M to $12.56M, a decrease of -88.65%. That is a compound annual growth rate of -17.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 12.60M | -18.71% |
| Dec 31, 2024 | 15.50M | -63.95% |
| Dec 29, 2023 | 43.00M | 405.88% |
| Dec 30, 2022 | 8.50M | -75.15% |
| Dec 31, 2021 | 34.20M | -65.77% |
| Dec 31, 2020 | 99.90M | -64.00% |
| Dec 31, 2019 | 277.50M | 5.92% |
| Dec 31, 2018 | 262.00M | 11.92% |
| Dec 29, 2017 | 234.10M | -42.76% |
| Dec 30, 2016 | 409.00M | 172.49% |
| Dec 31, 2015 | 150.10M | 35.23% |
| Dec 31, 2014 | 111.00M | 0.36% |
| Jul 1, 2014 | 110.60M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 687.62B |
| Johnson & Johnson | 411.20B |
| AbbVie | 350.75B |
| AstraZeneca | 231.42B |
| Novartis AG | 228.98B |
| UnitedHealth Group | 227.69B |
| Abbott Laboratories | 227.46B |
| Novo Nordisk | 210.71B |